Two Sigma Investments, LP Salarius Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.34 - $0.54 $30,760 - $48,854	-90,471 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.49 - $1.01 $34,863 - $71,861	71,150 Added 368.25%	90,471 $45,000
Q3 2021 Nov 15, 2021	BUY	$0.8 - $1.15 $15,456 - $22,219	19,321 New	19,321 $20,000
Q4 2020 Feb 16, 2021	SELL	$0.65 - $1.34 $7,553 - $15,572	-11,621 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.77 - $1.52 $8,948 - $17,663	11,621 New	11,621 $10,000

Ticker SLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,244,650
Market Cap $5.1M
Description
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a ...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.